Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChiroSolve is a life sciences company specializing in the rapid development of chiral separation processes for the pharmaceutical and chemical industries. The company provides automated chiral resolution screening kits and professional services to help researchers identify the most efficient methods for separating enantiomers. By utilizing a proprietary library of resolving agents and optimized solvent systems, ChiroSolve enables significant reductions in the time and cost associated with developing pure chiral intermediates and active pharmaceutical ingredients (APIs). Their offerings support drug discovery and development from early-stage research through to large-scale manufacturing. The company's technology focuses on diastereomeric crystallization, offering a scalable and cost-effective alternative to chiral chromatography.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChiroSolve.